Advertisement
Document › Details
elbion AG. (1/10/05). "Press Release: Elbion AG Completes € 25 Millionen Series A Financing". Dresden & Radebul.
![]() |
Organisation | Elbion AG |
| Today | Biocrea GmbH | |
| Group | Biocrea GmbH | |
| Organisation 2 | 3i (Group) | |
![]() |
Index term | Elbion–SEVERAL: investment, 200501–200505 1st financing round €35m private co-led by 3i + Burrill & Co + DVC |
Original Document
accessed by [iito] on 2005-01-15
Record changed: 2011-11-25 |
Advertisement
More documents for Biocrea GmbH
- [1] Biocrea GmbH. (4/22/13). "Press Release: Biocrea to Develop a Human Neuron Screening Platform for the Discovery of Novel Treatments for Neurodegenerative Diseases with Neuroscientists from the Dresden University of Technology". Radebeul....
- [2] Biocrea GmbH. (2/29/12). "Press Release: Biocrea and Boehringer Ingelheim Conclude Asset Purchase Agreement". Radebeul....
- [3] Biocrea GmbH. (5/10/11). "Press Release: Biocrea and Pfizer Jointly Presented Details on Novel PDE10 Inhibitors at the 241st ACS National Meeting & Exposition. Novel Treatment Opportunities for CNS Diseases". Radebeul....
- [4] Biocrea GmbH. (2/14/11). "Press Release: Biocrea Announces Novel Treatment Opportunities for CNS Diseases. Company Has Filed US Patent on Novel, Brain-penetrating PDE2 and PD10 Inhibitors". Radebeul....
- [5] Biocrea GmbH. (12/16/10). "Press Release: Biocrea erweitert Unternehmensführung. Ernennung von Martin Gunthorpe (Leiter Forschung), Viktor Viehweg (Leiter Finanzen) und Simon Ward (Leiter Chemie & Entwicklung)". Radebeul....
- [6] Biocrea GmbH. (11/4/10). "Press Release: Biocrea Acquires CNS Pipeline and PDE Inhibitor Platform from Biotie Therapies Corp., Announces Corporate Strategy. New Entity Will Be Based in Radebeul, Germany". Radebeul....
- [7] Biotie Therapies Corporation. (11/14/08). "Press Release: The Acquisition of the Pharmaceutical Development Company Elbion GmbH Completed"....
- [8] elbion AG. (12/5/06). "Press Release: elbion Merges with 4AZA to Form Leading European Drug Discovery and Development Company". Leuven & Dresden/Radebeul....
- [9] elbion AG. (5/24/05). "Press Release: Elbion AG Increases Series A Financing to €35 Million". Dresden & Radebeul....
- [10] elbion AG. (12/3/03). "Press Release: Encouraging Clinical Results for AWD 12-821 Presented on GSK’s R&D-Day". Radebeul....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg)







![Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)